Citation 83758

AGETA,H: AIMI,N: EBIZUKA,Y: FUJITA,T: HONDA,G:. (1998). TOWARDS NATURAL MEDICINE RESEARCH IN THE 21ST CENTURY.. 1998()

Citation Details

Title	TOWARDS NATURAL MEDICINE RESEARCH IN THE 21ST CENTURY.
Authors	AGETA,H: AIMI,N: EBIZUKA,Y: FUJITA,T: HONDA,G:
Year	1998
Volume	1998
Issue

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Lespedeza homoloba (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HAGININ E	None
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ E	ACTIVE
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ E	INACTIVE
7	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ E	ACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	HAGININ D	None
9	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ D	ACTIVE
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ D	INACTIVE
11	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HAGININ D	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PTERPOCARP-6(A)-EN-E,3-9-DIHYDROXY:	None
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERPOCARP-6(A)-EN-E,3-9-DIHYDROXY:	ACTIVE
14	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERPOCARP-6(A)-EN-E,3-9-DIHYDROXY:	INACTIVE
15	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PTERPOCARP-6(A)-EN-E,3-9-DIHYDROXY:	ACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL A-1	None
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-1	ACTIVE
18	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-1	WEAK ACTIVITY
19	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-1	ACTIVE
20	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL A-2	None
21	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-2	ACTIVE
22	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-2	ACTIVE
23	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-2	ACTIVE
24	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL A-3	None
25	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-3	ACTIVE
26	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-3	ACTIVE
27	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL A-3	ACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATA	BENZOFURAN,2-(2-4-DIHYDROXY-PHENYL)-6-HYDROXY:	None
29	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,2-(2-4-DIHYDROXY-PHENYL)-6-HYDROXY:	ACTIVE
30	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,2-(2-4-DIHYDROXY-PHENYL)-6-HYDROXY:	INACTIVE
31	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOFURAN,2-(2-4-DIHYDROXY-PHENYL)-6-HYDROXY:	ACTIVE
32	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL B-1	None
33	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-1	ACTIVE
34	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-1	ACTIVE
35	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-1	ACTIVE
36	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL B-2	None
37	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-2	ACTIVE
38	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-2	INACTIVE
39	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-2	ACTIVE
40	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL B-3	None
41	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-3	ACTIVE
42	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-3	ACTIVE
43	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL B-3	ACTIVE
44	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEDEZOL C-1	None
45	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL C-1	ACTIVE
46	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL C-1	ACTIVE
47	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEDEZOL C-1	ACTIVE

Citation 83758

Citation Details

Summary

Organisms and Their Experiments (1)

Lespedeza homoloba (FABACEAE)

Show SPARQL Queries (1)

Query 1